Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma

Natural Compounds in Liposomal Nanoformulations of Potential Clinical Application in Glioblastoma

Glioblastoma (GBM) is the most common malignant neoplasm in adults among all CNS gliomas, with the 5-year survival rate being as low as 5%. Among nanocarriers, liposomal nanoformulations are considered as a promising tool for precise drug delivery. The herein presented study demonstrates the possibi...

Full description

Bibliographic Details
Main Authors: Ludwika Piwowarczyk, Dariusz T. Mlynarczyk, Violetta Krajka-Kuźniak, Aleksandra Majchrzak-Celińska, Anna Budzianowska, Szymon Tomczak, Jaromir Budzianowski, Aneta Woźniak-Braszak, Rafał Pietrzyk, Mikołaj Baranowski, Tomasz Goslinski, Anna Jelinska
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Cancers
Subjects:
cancer
glioblastoma
liposomes
natural compounds
drug delivery system
Online Access:https://www.mdpi.com/2072-6694/14/24/6222

Internet

https://www.mdpi.com/2072-6694/14/24/6222

Similar Items